The global landscape of ocular health is on the verge of a significant transformation, poised for a remarkable surge with the Global Ocular Tuberculosis Therapeutics Industry projected to reach a noteworthy US$753.2 million valuation by 2032. This forecast showcases a substantial increase from the US$405.0 million recorded in 2022, highlighting the industry’s impressive growth trajectory. …